DEINOVE announced that its Boost-ID project (Bacteria Optimum Output Screening Tool for treating Infectious Diseases) is one of 105 projects selected by the French government, out of nearly 1,000 presented, as part of the call for resilience projects. The grant, which is expected to amount to €500,000 to $800,000, is intended to support the Boost-ID project, estimated at just over €1 million in total, and will enable DEINOVE to set up an industrial plant for sorting bacteria at very high throughput, based on droplet-based microfluidics. Boost-ID is a continuation of the Deinodrop project granted by the National Research Agency. DEINOVE will build a breakthrough technology, at the interface of physics and modern biology. Boost-ID will accelerate the selective isolation of bacteria with antimicrobial potential from environmental samples and will become the first screening step of DEINOVE. Microfluidics is based on the manipulation of infinitely small volumes and at very high throughput. Boost-ID will thus increase the platform’s current performance while reducing its costs. The bacterial strains with the most promising activities, detected in microfluidics, will then go through the automated extraction steps, requiring larger volumes, to be tested on reference panels. The large proportion of metabolites being of a clinical nature too complex for synthetic chemistry, DEINOVE’s fermentation bioproduction capabilities and know-how will then come into play to obtain the critical mass and quality for their preclinical and clinical evaluations. From picoliter to 20 liters, the Company is strengthening its position as an industrial biotech dedicated to the identification of gold nuggets of natural origin, from the 99.9% unexplored microbial dark matter. With a major gain in yield upstream of the process, Boost-ID will accelerate the development of new antimicrobials and molecules of natural origin with high added value.